In a recent Nature article, Koeber et al. engineer synthetic super-enhancers from glioblastoma-specific regulatory circuitry to act as precise gene switches. Combined with viral delivery of cytotoxic and immune-stimulating payloads, this approach activates therapy selectively in tumor cells, enabling targeted tumor clearance and durable immune memory.
